SLC5A2 and Cirrhosis: Mendelian randomization (MR) was performed using single-nucleotide polymorphisms (SNPs) within the SLC5A2 locus as genetic instruments to evaluate the causal effect of SGLT2 inhibition on liver fibrosis and cirrhosis.